An in vitro study to investigate the interference of enoxaparin on plasma levels of direct oral factor Xa inhibitors measured by chromogenic assays

INTRODUCTION: Co‐administration of enoxaparin and a direct oral factor Xa inhibitor (xabans: apixaban, edoxaban, rivaroxaban) could give rise to the problem of overlapping the anti‐Xa activity when measuring direct oral anticoagulant (DOAC) levels. We aimed to evaluate in vitro the degree of the int...

Descripción completa

Detalles Bibliográficos
Autores principales: Cini, Michela, Legnani, Cristina, Testa, Sophie, Tripodi, Armando, Cosmi, Benilde, Palareti, Gualtiero
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850445/
https://www.ncbi.nlm.nih.gov/pubmed/30698331
http://dx.doi.org/10.1111/ijlh.12974

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850445/
https://www.ncbi.nlm.nih.gov/pubmed/30698331
http://dx.doi.org/10.1111/ijlh.12974

Ejemplares similares